Checkpoint Inhibitors | Unleashing the Immune System Against Cancer | Pembrolizumab

Поділитися
Вставка
  • Опубліковано 2 жов 2024

КОМЕНТАРІ • 3

  • @giterdunpete
    @giterdunpete 7 місяців тому +1

    Say what?

  • @JamesBond-td7li
    @JamesBond-td7li 7 місяців тому +1

    What is the latest news on AOH 1996 ?

    • @NerdNucleus-eg4ji
      @NerdNucleus-eg4ji  Місяць тому

      Currently in Phase I clinical trials, primarily targeting solid tumors. .Early results are encouraging, showing that AOH1996 can selectively kill cancer cells while sparing healthy ones. However, it is still in the early stages of testing, and more research is needed to confirm its efficacy and safety.